parliament Courtesy: Shahnoor Habib Munmum/Wikimedia Commons
10 January 2014

FDI pharma policy needs unusual answers

The issue of foreign direct investment in pharmaceuticals has come under attack from many lobbies. The answers lie in the public sector or public distribution mechanisms. Addressing public health concerns without vitiating the investment climate must be one of the key priorities of the next government